BSEBoard Meeting6d ago · 1 Aug 2026, 03:51 pm
Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve please refer attachment
Emmessar Biotech & Nutrition Ltd · 524768
✦ AI SummaryResults
Emmessar Biotech & Nutrition Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 07/08/2026 to consider and approve unaudited Financial Results for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026
Attachments (1)
📄pdf
Download →
e2d23b80-752e-41af-b6ee-a5437688e77f.pdf
View document text
EMMESSAR BIOTECH & NUTRITION LIMITED
29, Kamer Building, 4th floor, 38, Cawasji Patel Street, Fort, Mumbai – 400 001
Tel: 022-35661373 / 35664530 Email: enquiries@ebnl.org Website: www.ebnl.org
Investors Grievance Email: investors@ebnl.org CIN No. L24110MH1992PLC065942
Date: August 01, 2026
The Manager
Listing Department,
Bombay Stock Exchange Limited,
P. J. Tower,
Dalal Street,
Mumbai – 400 001
Ref: -Security Code No. 524768
Sub: Intimation of Board Meeting –Audited Financial Results
Dear Sir/Madam,
This is to inform you, pursuant to Regulation 29 (1) (a) of Securities and Exchange Board of India
(Listing Obligations and Disclosure requirements) Regulations, 2015, that a meeting of the Board of
Directors of the Company will be held on Friday the August 07, 2026, at Mumbai, inter alia:
To consider and approve unaudited Financial Results of the Company for the quarter ended June 30,
2026.
Further, pursuant SEBI (Prohibition of Insider Trading), Regulations, 2015, as amended from time to
time the Trading Window, as informed to the exchange vide letter dated 26.06.2026 in respect of trading
in equity shares of the Company will remain closed upto August 09, 2026.
Kindly take the above on your record and oblige.
Thanking you,
Yours faithfully,
For EMMESSAR BIOTECH & NUTRITION LIMITED
Priyanka Sharma
Company Secretary
Regd. Office & Factory: Plot No. T-3/2, MIDC Area, Taloja – 410208. Dist. Raigad. Maharashtra.
Email: enquiries@ebnl.org Website: www.ebnl.org